PMV PHARMACEUTICALS INC. - COMMON STOCK

PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights

10 май 2023 08:00:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights

01 мар 2023 08:00:02 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March

28 фев 2023 16:05:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference 

22 ноя 2022 08:00:02 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights

08 ноя 2022 08:00:03 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors

04 ноя 2022 08:00:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Second Quarter 2022 Financial Results and Corporate Highlights

09 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors

18 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference

08 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation

07 июн 2022 12:00:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

26 май 2022 17:05:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights

10 май 2022 07:30:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

27 апр 2022 10:30:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights

01 мар 2022 07:15:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference

28 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day

03 фев 2022 08:00:02 Источник Nasdaq GlobeNewswire

PMV Pharma Announces Changes to its Board of Directors

06 янв 2022 08:00:03 Источник Nasdaq GlobeNewswire

PMV Pharma to Present at the Evercore ISI 4th Annual HealthCONx Conference

22 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights

12 ноя 2021 07:15:00 Источник Nasdaq GlobeNewswire

PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development

09 сен 2021 08:00:03 Источник Nasdaq GlobeNewswire